“APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS”, Mediterr J Hematol Infect Dis, vol. 10, no. 1, p. e2018028, May 2018, doi: 10.4084/mjhid.2018.028.